Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Neil Martinson and Ziyaad Waja.
Connection Strength

1,568
  1. Exhaled breath specimens subjected to point-of-care lipoarabinomannan testing. Int J Tuberc Lung Dis. 2023 09 01; 27(9):703-705.
    View in: PubMed
    Score: 0,227
  2. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV. BMC Infect Dis. 2021 May 22; 21(1):466.
    View in: PubMed
    Score: 0,194
  3. Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppression. Tuberculosis (Edinb). 2021 01; 126:102023.
    View in: PubMed
    Score: 0,187
  4. Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso Cohort. Clin Infect Dis. 2020 09 12; 71(6):1419-1426.
    View in: PubMed
    Score: 0,185
  5. Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV. Int J Tuberc Lung Dis. 2020 07 01; 24(7):681-685.
    View in: PubMed
    Score: 0,182
  6. Clinical Strains of Mycobacterium tuberculosis Representing Different Genotype Families Exhibit Distinct Propensities to Adopt the Differentially Culturable State. Pathogens. 2024 Apr 12; 13(4).
    View in: PubMed
    Score: 0,059
  7. The performance of tongue swabs for detection of pulmonary tuberculosis. Front Cell Infect Microbiol. 2023; 13:1186191.
    View in: PubMed
    Score: 0,057
  8. SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen. Trials. 2023 Jun 28; 24(1):435.
    View in: PubMed
    Score: 0,056
  9. Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response. Front Cell Infect Microbiol. 2022; 12:1064148.
    View in: PubMed
    Score: 0,054
  10. Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility. Clin Immunol. 2021 09; 230:108824.
    View in: PubMed
    Score: 0,049
  11. Supplementation of sputum cultures with culture filtrate to detect tuberculosis in a cross-sectional study of HIV-infected individuals. Tuberculosis (Edinb). 2021 07; 129:102103.
    View in: PubMed
    Score: 0,049
  12. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 05 06; 384(18):1705-1718.
    View in: PubMed
    Score: 0,048
  13. Detection of differentially culturable tubercle bacteria in sputum using mycobacterial culture filtrates. Sci Rep. 2021 03 22; 11(1):6493.
    View in: PubMed
    Score: 0,048
  14. Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting. J Mol Diagn. 2020 10; 22(10):1225-1237.
    View in: PubMed
    Score: 0,046
  15. Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV. Antimicrob Agents Chemother. 2020 02 21; 64(3).
    View in: PubMed
    Score: 0,044
  16. Chronic HIV-1 Infection Alters the Cellular Distribution of Fc?RIIIa and the Functional Consequence of the Fc?RIIIa-F158V Variant. Front Immunol. 2019; 10:735.
    View in: PubMed
    Score: 0,042
  17. Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study. Clin Infect Dis. 2018 03 05; 66(6):921-929.
    View in: PubMed
    Score: 0,039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.